{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:25:50Z","timestamp":1792783550054,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Norte Portugal Regional Operational Programme","award":["NORTE-01-0145-FEDER-000012"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000012"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"Fundo Europeu de Desenvolvimento Regional","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-007274"],"award-info":[{"award-number":["POCI-01-0145-FEDER-007274"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/117598\/2016"],"award-info":[{"award-number":["SFRH\/BD\/117598\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.addr.2017.09.020","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T16:03:05Z","timestamp":1506614585000},"page":"98-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Chemical modification of drug molecules as strategy to reduce interactions with mucus"],"prefix":"10.1016","volume":"124","author":[{"given":"Francisca","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2017.09.020_bb0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","article-title":"Mucoadhesive vs. mucopenetrating particulate drug delivery","volume":"98","author":"Netsomboon","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2017.09.020_bb0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2017.09.020_bb0015","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.addr.2017.09.020_bb0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4155\/tde-2015-0002","article-title":"The properties of the mucus barrier, a unique gel\u2013how can nanoparticles cross it?","volume":"7","author":"Pearson","year":"2016","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.addr.2017.09.020_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1513\/pats.2306016","article-title":"From mucins to mucus: toward a more coherent understanding of this essential barrier","volume":"1","author":"Thornton","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.addr.2017.09.020_bb0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","article-title":"Micro- and macrorheology of mucus","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2017.09.020_bb0035","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/adma.201201800","article-title":"Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery","volume":"24","author":"Ensign","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2017.09.020_bb0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1166\/jnn.2014.9015","article-title":"Mucus as barrier for drug delivery by nanoparticles","volume":"14","author":"Frohlich","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.addr.2017.09.020_bb0045","doi-asserted-by":"crossref","first-page":"G922","DOI":"10.1152\/ajpgi.2001.280.5.G922","article-title":"The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo","volume":"280","author":"Atuma","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.addr.2017.09.020_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2017.09.020_bb0055","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1021\/bi00439a029","article-title":"Role of glycosylation on the conformation and chain dimensions of O-linked glycoproteins: light-scattering studies of ovine submaxillary mucin","volume":"28","author":"Shogren","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2017.09.020_bb0060","first-page":"G613","article-title":"Mucin gene structure and expression: protection vs. adhesion","volume":"269","author":"Van Klinken","year":"1995","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.addr.2017.09.020_bb0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0968-0004(01)02052-7","article-title":"The MUC family: an obituary","volume":"27","author":"Dekker","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.addr.2017.09.020_bb0070","series-title":"Mucosal Immunology","first-page":"49","article-title":"Mucus","author":"Cone","year":"2005"},{"key":"10.1016\/j.addr.2017.09.020_bb0075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.ph.57.030195.003223","article-title":"Mucin biophysics","volume":"57","author":"Bansil","year":"1995","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.addr.2017.09.020_bb0080","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1073\/pnas.0911748107","article-title":"Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses","volume":"107","author":"Lai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2017.09.020_bb0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcpt.12342","article-title":"Mucus as a barrier to drug delivery\u2013understanding and mimicking the barrier properties","volume":"116","author":"Boegh","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.addr.2017.09.020_bb0090","doi-asserted-by":"crossref","first-page":"19268","DOI":"10.1073\/pnas.0905998106","article-title":"Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier","volume":"106","author":"Tang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2017.09.020_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004294","article-title":"Altering mucus rheology to \u201csolidify\u201d human mucus at the nanoscale","volume":"4","author":"Lai","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2017.09.020_bb0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2014.12.004","article-title":"Polymer-based nanocarriers for vaginal drug delivery","volume":"92","author":"das Neves","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2017.09.020_bb0105","first-page":"196","article-title":"Comparative studies of mucus and mucin physicochemistry","volume":"109","author":"Litt","year":"1984","journal-title":"CIBA Found. Symp."},{"key":"10.1016\/j.addr.2017.09.020_bb0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2013.05.040","article-title":"Mucus as a barrier to lipophilic drugs","volume":"453","author":"Sigurdsson","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2017.09.020_bb0115","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.addr.2017.09.020_bb0120","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0006-3495(94)80802-1","article-title":"Antibody diffusion in human cervical mucus","volume":"66","author":"Saltzman","year":"1994","journal-title":"Biophys. J."},{"key":"10.1016\/j.addr.2017.09.020_bb0125","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1084\/jem.184.3.1045","article-title":"Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting","volume":"184","author":"Frey","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2017.09.020_bb0130","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijpharm.2016.10.039","article-title":"Buccal delivery of low molecular weight heparin by cationic polymethacrylate nanoparticles","volume":"515","author":"Mouftah","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2017.09.020_bb0135","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijpharm.2012.01.044","article-title":"Low molecular weight heparin gels, based on nanoparticles, for topical delivery","volume":"426","author":"Loira-Pastoriza","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"Part B","key":"10.1016\/j.addr.2017.09.020_bb0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","article-title":"Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues","volume":"106","author":"Lundquist","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2017.09.020_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2017.09.020_bb0150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fimmu.2013.00310","article-title":"The influence of mucus microstructure and rheology in Helicobacter pylori infection","volume":"4","author":"Bansil","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2017.09.020_bb0155","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jmb.2006.10.026","article-title":"Amino acid contribution to protein solubility: Asp, Glu, and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa","volume":"366","author":"Trevino","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.addr.2017.09.020_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00018-014-1756-3","article-title":"Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs","volume":"72","author":"Steinbach","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.addr.2017.09.020_bb0165","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/js960503w","article-title":"Diffusion of drugs in native and purified gastrointestinal mucus","volume":"86","author":"Larhed","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2017.09.020_bb0170","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1039\/an9911601113","article-title":"Estimation of effective diffusion coefficients of model solutes through gastric mucus: assessment of a diffusion chamber technique based on spectrophotometric analysis","volume":"116","author":"Desai","year":"1991","journal-title":"Analyst"},{"key":"10.1016\/j.addr.2017.09.020_bb0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/157488512803988076","article-title":"Recent advances in nasal drug delivery using natural polymers","volume":"7","author":"Nirmala","year":"2012","journal-title":"Curr. Drug Ther."},{"key":"10.1016\/j.addr.2017.09.020_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0169-409X(93)90040-B","article-title":"Mechanisms, barriers and pathways of oral mucosal drug permeation","volume":"12","author":"Rathbone","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2017.09.020_bb0185","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejpb.2015.01.022","article-title":"Nano-carrier systems: strategies to overcome the mucus gel barrier","volume":"96","author":"D\u00fcnnhaupt","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2017.09.020_bb0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cbpa.2015.08.009","article-title":"Protein\u2013polymer conjugation\u2014moving beyond PEGylation","volume":"28","author":"Qi","year":"2015","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.addr.2017.09.020_bb0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0141-8130(02)00036-3","article-title":"Bioadhesive properties of polygalacturonides against colonic epithelial membranes","volume":"30","author":"Schmidgall","year":"2002","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2017.09.020_bb0200","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1021\/bm501832y","article-title":"Biophysical analysis of the molecular interactions between polysaccharides and mucin","volume":"16","author":"Menchicchi","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2017.09.020_bb0205","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2017.09.020_bb0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2014.03.041","article-title":"Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8+ T cell responses","volume":"191","author":"Keller","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2017.09.020_bb0215","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1039\/b907061c","article-title":"Synthesis and bioactivity of poly (HPMA)\u2013lysozyme conjugates: the use of novel thiazolidine-2-thione coupling chemistry","volume":"7","author":"Tao","year":"2009","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.addr.2017.09.020_bb0220","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1021\/bm900678r","article-title":"Branched polymer\u2212 protein conjugates made from mid-chain-functional P (HPMA)","volume":"10","author":"Tao","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2017.09.020_bb0225","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1039\/C6TB02475K","article-title":"A strategy for developing effective orally-delivered nanoparticles through modulation of the surface \u201chydrophilicity\/hydrophobicity balance\u201d","volume":"5","author":"Cui","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2017.09.020_bb0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.12.008","article-title":"Efficient mucus permeation and tight junction opening by dissociable \u201cmucus-inert\u201d agent coated trimethyl chitosan nanoparticles for oral insulin delivery","volume":"222","author":"Liu","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2017.09.020_bb0235","unstructured":"S. Quay, M. Gupta, J. de Meireles, M.A. El-Shafy, Patent EP1539220, 2003."},{"key":"10.1016\/j.addr.2017.09.020_bb0240","unstructured":"H. Costantino, R. Herman, M. Houston, P. Johnson, R. Rana, Patent US20060069021, 2005."},{"key":"10.1016\/j.addr.2017.09.020_bb0245","unstructured":"S. Quay, H. Costantino, Patent US20050143303, 2004."},{"key":"10.1016\/j.addr.2017.09.020_bb0250","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1021\/la5000765","article-title":"Development of zwitterionic polymer-based doxorubicin conjugates: tuning the surface charge to prolong the circulation and reduce toxicity","volume":"30","author":"Wang","year":"2014","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2017.09.020_bb0255","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/S0968-0896(02)00239-0","article-title":"5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods","volume":"10","author":"Herr","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2017.09.020_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nchem.1230","article-title":"Relieving PEGylation","volume":"4","author":"Parrott","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.addr.2017.09.020_bb0265","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nchem.1213","article-title":"Poly (zwitterionic) protein conjugates offer increased stability without sacrificing binding affinity or bioactivity","volume":"4","author":"Keefe","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.addr.2017.09.020_bb0270","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0169-409X(01)00115-6","article-title":"Drug transfer through mucus","volume":"48","author":"Khanvilkar","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2017.09.020_bb0275","first-page":"799","article-title":"Peroral polypeptide delivery","volume":"49","author":"Bernkop-Schn\u00fcrch","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.addr.2017.09.020_bb0280","first-page":"3","article-title":"Role of N-acetylcysteine in the management of COPD","volume":"2","author":"Sadowska","year":"2006","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.addr.2017.09.020_bb0285","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2015.01.004","article-title":"Mucus permeating thiomer nanoparticles","volume":"97","author":"K\u00f6llner","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2017.09.020_bb0290","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/oxfordjournals.jbchem.a122378","article-title":"Two types of rat gastric mucus glycoprotein subunits","volume":"103","author":"Ohara","year":"1988","journal-title":"J. Biochem."},{"key":"10.1016\/j.addr.2017.09.020_bb0295","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/03639045.2013.877481","article-title":"Development of papain containing pellets produced by extrusion\u2013spheronization: an operational stage approach","volume":"41","author":"Varca","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2017.09.020_bb0300","first-page":"2","article-title":"Therapeutic approach to mucociliary disorders","volume":"1","author":"Grossan","year":"2017","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.addr.2017.09.020_bb0305","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s11095-006-9226-8","article-title":"Papain: an effective permeation enhancer for orally administered low molecular weight heparin","volume":"24","author":"Grabovac","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2017.09.020_bb0310","doi-asserted-by":"crossref","first-page":"30433","DOI":"10.1074\/jbc.274.43.30433","article-title":"Cysteine proteinase activity regulation. A possible role of heparin and heparin-like glycosaminoglycans","volume":"274","author":"Almeida","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2017.09.020_bb0315","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/jb\/46.5.653","article-title":"A proteolytic enzyme of Streptomyces griseus: I. Purification of a protease of Streptomyces griseus","volume":"46","author":"Nomoto","year":"1959","journal-title":"J. Biochem."},{"key":"10.1016\/j.addr.2017.09.020_bb0320","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1055\/s-2002-33220","article-title":"A defoaming agent should be used with pronase premedication to improve visibility in upper gastrointestinal endoscopy","volume":"34","author":"Kuo","year":"2002","journal-title":"Endoscopy"},{"key":"10.1016\/j.addr.2017.09.020_bb0325","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1128\/AAC.02319-13","article-title":"Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication","volume":"58","author":"Liu","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2017.09.020_bb0330","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1523-5378.2002.00079.x","article-title":"Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori","volume":"7","author":"Gotoh","year":"2002","journal-title":"Helicobacter"},{"key":"10.1016\/j.addr.2017.09.020_bb0335","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2004.09.023","article-title":"Improved paracellular uptake by the combination of different types of permeation enhancers","volume":"288","author":"Guggi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2017.09.020_bb0340","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/10942910801942483","article-title":"Retention of the enzymatic activity and product properties during spray drying of pineapple stem extract in presence of maltodextrin","volume":"12","author":"Cabral","year":"2009","journal-title":"Int. J. Food Prop."},{"key":"10.1016\/j.addr.2017.09.020_bb0345","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0015-0282(16)31868-4","article-title":"Cervicohysterosalpingography: preliminary report on a new cannula and technic","volume":"6","author":"Hunter","year":"1955","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.addr.2017.09.020_bb0350","series-title":"3rd International Conference on Instrumentation, Communications, Information Technology, and Biomedical Engineering (ICICI-BME)","first-page":"313","article-title":"Development and optimization of instant drink formulation from pineapple (Ananas cosmosus) juice","author":"Pandjaitan","year":"2013"},{"key":"10.1016\/j.addr.2017.09.020_bb0355","doi-asserted-by":"crossref","first-page":"1441013","DOI":"10.1142\/S179398441441013X","article-title":"Enzyme-functionalized PLGA nanoparticles with enhanced mucus permeation rate","volume":"4","author":"Samaridou","year":"2014","journal-title":"Nano Life"},{"key":"10.1016\/j.addr.2017.09.020_bb0360","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1164\/ajrccm\/140.4.1172","article-title":"Drugs in bronchial mucology","volume":"140","author":"Ventresca","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.addr.2017.09.020_bb0365","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jconrel.2005.09.047","article-title":"Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant","volume":"110","author":"Matsuyama","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2017.09.020_bb0370","first-page":"361","article-title":"Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration","volume":"2","author":"Bernkop-Schn\u00fcrch","year":"1996","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.addr.2017.09.020_bb0375","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2006.08.004","article-title":"Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent","volume":"115","author":"Matsuyama","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2017.09.020_bb0380","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0016-5085(89)91416-9","article-title":"Bacterial chemotactic oligopeptides and the intestinal mucosal barrier","volume":"97","author":"Ferry","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2017.09.020_bb0385","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11882-005-0044-6","article-title":"Therapeutic approaches to mucus hypersecretion","volume":"5","author":"Yuta","year":"2005","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.addr.2017.09.020_bb0390","unstructured":"P. Foresta, O. Ghirardi, B. Gabetta, A. Cristoni, Patent US4879376, 1989."},{"key":"10.1016\/j.addr.2017.09.020_bb0395","series-title":"Strategies and Future Trends","article-title":"Oral delivery of macromolecular drugs: barriers","author":"Bernkop-Schn\u00fcrch","year":"2009"},{"key":"10.1016\/j.addr.2017.09.020_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2527\/jas2000.00218812007700ES0009x","article-title":"Actual and potential applications of and saponins in human and animal nutrition","volume":"77","author":"Cheeke","year":"2000","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.addr.2017.09.020_bb0405","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1023\/A:1016235705448","article-title":"A semisynthetic Quillaja saponin as a drug delivery agent for aminoglycoside antibiotics","volume":"12","author":"Recchia","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2017.09.020_bb0410","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1148\/104.1.153","article-title":"Cholerheic enteropathy as a cause of diarrhea and death in radiation enteritis and its prevention with Cholestyramine 1","volume":"104","author":"Berk","year":"1972","journal-title":"Radiology"},{"key":"10.1016\/j.addr.2017.09.020_bb0415","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jps.2600760502","article-title":"Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep","volume":"76","author":"Longenecker","year":"1987","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2017.09.020_bb0420","first-page":"662","article-title":"Measurement of sputum viscosity in a cone-plate viscometer 1: II. An evaluation of mucolytic agents in vitro","volume":"97","author":"Lieberman","year":"1968","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.addr.2017.09.020_bb0425","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF00731190","article-title":"The roles of enteric bacterial sialidase, sialate O-acetyl esterase and glycosulfatase in the degradation of human colonic mucin","volume":"10","author":"Corfield","year":"1993","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.addr.2017.09.020_bb0430","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prrv.2007.02.009","article-title":"Mucolytics in cystic fibrosis","volume":"8","author":"Henke","year":"2007","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.addr.2017.09.020_bb0435","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11095-009-9991-2","article-title":"Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis","volume":"27","author":"Yang","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2017.09.020_bb0440","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2017.09.020_bb0445","first-page":"118","article-title":"Gaining the upper hand on pulmonary drug delivery","volume":"2","author":"Tyrrell","year":"2014","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.addr.2017.09.020_bb0450","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1134\/S1819712412020080","article-title":"Intranasal administration: a prospective drug delivery route to the brain","volume":"6","author":"Privalova","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2017.09.020_bb0455","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1359-6446(02)02452-2","article-title":"Permeability issues in nasal drug delivery","volume":"7","author":"Arora","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2017.09.020_bb0460","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ddtec.2005.05.018","article-title":"Buccal drug delivery: a challenge already won?","volume":"2","author":"Rossi","year":"2005","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.addr.2017.09.020_bb0465","series-title":"Medical toxicology","author":"Dart","year":"2004"},{"key":"10.1016\/j.addr.2017.09.020_bb0470","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molstruc.2010.11.049","article-title":"Adsorption investigation of MA-DTPA chelating resin for Ni (II) and Cu (II) using experimental and DFT methods","volume":"986","author":"Zhao","year":"2011","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.addr.2017.09.020_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(97)00204-6","article-title":"The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins","volume":"52","author":"Bernkop-Schn\u00fcrch","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2017.09.020_bb0480","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","article-title":"Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery","volume":"33","author":"Su","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2017.09.020_bb0485","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/03639040600712953","article-title":"Transport characteristics of a beta sheet breaker peptide across excised bovine nasal mucosa","volume":"33","author":"Greimel","year":"2007","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2017.09.020_bb0490","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0361-9230(87)90178-X","article-title":"Amastatin and bestatin-Induced dipsogenicity in the fSprague-Dawley Rat","volume":"19","author":"Quirk","year":"1987","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.addr.2017.09.020_bb0495","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0378-5173(88)90263-3","article-title":"Buccal drug absorption. I. Comparative levels of esterase and peptidase activities in rat and hamster buccal and intestinal homogenates","volume":"48","author":"Garren","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2017.09.020_bb0500","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-3542(97)00052-1","article-title":"Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection","volume":"36","author":"Pulido-Cejudo","year":"1997","journal-title":"Antivir. Res."},{"key":"10.1016\/j.addr.2017.09.020_bb0505","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/138920007780866834","article-title":"Presystemic metabolism of orally administered peptide drugs and strategies to overcome it","volume":"8","author":"Bernkop-Schnurch","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.addr.2017.09.020_bb0510","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1023\/A:1015884026056","article-title":"Nasal absorption enhancers for biosynthetic human growth hormone in rats","volume":"7","author":"O'hagan","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2017.09.020_bb0515","series-title":"Patent US4537773","article-title":"Shenvi","author":"A.B","year":"1985"},{"key":"10.1016\/j.addr.2017.09.020_bb0520","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1023\/A:1015949013644","article-title":"The use of \u03b1-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption","volume":"6","author":"Hussain","year":"1989","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2017.09.020_bb0525","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/0024-3205(90)90492-A","article-title":"Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: implications in peptide delivery from nonoral routes","volume":"47","author":"Yamamoto","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2017.09.020_bb0530","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1128\/JB.01132-07","article-title":"Resistance to bacitracin in Bacillus subtilis: unexpected requirement of the BceAB ABC transporter in the control of expression of its own structural genes","volume":"189","author":"Bernard","year":"2007","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.addr.2017.09.020_bb0535","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1773-2247(04)50090-4","article-title":"Polymer-enzyme inhibitor conjugates: influence of the molecular mass on the inhibition of membrane-bound aminopeptidase N activity","volume":"14","author":"Leitner","year":"2004","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.addr.2017.09.020_bb0540","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1023\/A:1015947509295","article-title":"The adjuvant effect of bacitracin on nasal absorption of gonadorelin and buserelin in rats","volume":"5","author":"Raehs","year":"1988","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2017.09.020_bb0545","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1463-1326.2007.00823.x","article-title":"PEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db\/db mice","volume":"10","author":"Youn","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.addr.2017.09.020_bb0550","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0168-3659(92)90075-3","article-title":"Trials of lipid modification of peptide hormones for intestinal delivery","volume":"19","author":"Muranishi","year":"1992","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2017.09.020_bb0555","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1023\/A:1015896405389","article-title":"Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats","volume":"8","author":"Merkus","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2017.09.020_bb0560","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1096\/fasebj.30.1_supplement.842.8","article-title":"L- to D- amino acid substitution impacts the cellular penetration activity and the intracellular behavior of the endosomolytic delivery agent dfTAT","volume":"30","author":"Najjar","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2017.09.020_bb0565","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0024-3205(79)90159-0","article-title":"Structure activity relationship of orally active enkephalin analogues as analgesics","volume":"24","author":"Roemer","year":"1979","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2017.09.020_bb0570","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1397-002x.2001.10994.x","article-title":"Determination of stereochemistry stability coefficients of amino acid side-chains in an amphipathic alpha-helix","volume":"59","author":"Chen","year":"2002","journal-title":"J. Pept. Res."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X17302016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X17302016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:39:44Z","timestamp":1759207184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X17302016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":114,"alternative-id":["S0169409X17302016"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2017.09.020","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical modification of drug molecules as strategy to reduce interactions with mucus","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2017.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}